To our surprise, the preliminary analysis showed that TRIM71 exhibits no significant prognostic value in the overall ovarian cancer patients or the TP53-mutated ovarian cancer patients, although high level of TRIM71 is moderately associated with survival of these patients (Fig. 7a, b). This evidence concerns the gene TP53 and ovarian cancer.